Literature DB >> 21964979

Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis?

Tianfu Li1, Nikki Lytle, Jing-Quan Lan, Ursula S Sandau, Detlev Boison.   

Abstract

Astrogliosis and associated dysfunction of adenosine homeostasis are pathological hallmarks of the epileptic brain and thought to contribute to seizure generation in epilepsy. The authors hypothesized that astrogliosis-an early component of the epileptogenic cascade-might be linked to focal seizure onset. To isolate the contribution of astrogliosis to ictogenesis from other pathological events involved in epilepsy, the authors used a minimalistic model of epileptogenesis in mice, based on a focal onset status epilepticus triggered by intra-amygdaloid injection of kainic acid. The authors demonstrate acute neuronal cell loss restricted to the injected amygdala and ipsilateral CA3, followed 3 weeks later by focal astrogliosis and overexpression of the adenosine-metabolizing enzyme adenosine kinase (ADK). Using synchronous electroencephalographic recordings from multiple depth electrodes, the authors identify the KA-injected amygdala and ipsilateral CA3 as two independent foci for the initiation of non-synchronized electrographic subclinical seizures. Importantly, seizures remained focal and restricted to areas of ADK overexpression. However, after systemic application of a non-convulsive dose of an adenosine A(1) -receptor antagonist, seizures in amygdala and CA3 immediately synchronized and spread throughout the cortex, leading to convulsive seizures. This focal seizure phenotype remained stable over at least several weeks. We conclude that astrogliosis via disruption of adenosine homeostasis per se and in the absence of any other overt pathology, is associated with the emergence of spontaneous recurrent subclinical seizures, which remain stable over space and time. A secondary event, here mimicked by brain-wide disruption of adenosine signaling, is likely required to turn pre-existing subclinical seizures into a clinical seizure phenotype.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964979      PMCID: PMC3217085          DOI: 10.1002/glia.21250

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  36 in total

1.  Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy.

Authors:  Detlev Boison; Susan A Masino; Jonathan D Geiger
Journal:  Expert Opin Drug Discov       Date:  2011-07       Impact factor: 6.098

2.  A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors.

Authors:  Susan A Masino; Tianfu Li; Panos Theofilas; Ursula S Sandau; David N Ruskin; Bertil B Fredholm; Jonathan D Geiger; Eleonora Aronica; Detlev Boison
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

Review 3.  Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies.

Authors:  Detlev Boison
Journal:  Neuroscientist       Date:  2005-02       Impact factor: 7.519

Review 4.  Astrocyte dysfunction in epilepsy.

Authors:  Gerald Seifert; Giorgio Carmignoto; Christian Steinhäuser
Journal:  Brain Res Rev       Date:  2009-10-31

5.  A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs.

Authors:  Hai-Ying Shen; Joana E Coelho; Nobuhisa Ohtsuka; Paula M Canas; Yuan-Ji Day; Qing-Yuan Huang; Nelson Rebola; Liqun Yu; Detlev Boison; Rodrigo A Cunha; Joel Linden; Joe Z Tsien; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

Review 6.  Adenosine signaling and function in glial cells.

Authors:  D Boison; J-F Chen; B B Fredholm
Journal:  Cell Death Differ       Date:  2009-09-18       Impact factor: 15.828

7.  A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children.

Authors:  L E Rosengren; G Ahlsén; M Belfrage; C Gillberg; K G Haglid; A Hamberger
Journal:  J Neurosci Methods       Date:  1992-09       Impact factor: 2.390

8.  Silk polymer-based adenosine release: therapeutic potential for epilepsy.

Authors:  Andrew Wilz; Eleanor M Pritchard; Tianfu Li; Jing-Quan Lan; David L Kaplan; Detlev Boison
Journal:  Biomaterials       Date:  2008-06-02       Impact factor: 12.479

9.  Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice.

Authors:  Tianfu Li; Jing-Quan Lan; Detlev Boison
Journal:  Neuron Glia Biol       Date:  2009-08-13

10.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

View more
  27 in total

Review 1.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

2.  Genetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy development.

Authors:  Matthew L Diamond; Anne C Ritter; Edwin K Jackson; Yvette P Conley; Patrick M Kochanek; Detlev Boison; Amy K Wagner
Journal:  Epilepsia       Date:  2015-06-04       Impact factor: 5.864

Review 3.  The role of adenosine in epilepsy.

Authors:  Landen Weltha; Jesica Reemmer; Detlev Boison
Journal:  Brain Res Bull       Date:  2018-11-20       Impact factor: 4.077

4.  Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity.

Authors:  Ditte Lovatt; Qiwu Xu; Wei Liu; Takahiro Takano; Nathan A Smith; Jurgen Schnermann; Kim Tieu; Maiken Nedergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

Review 5.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 6.  Adenosine dysfunction in epilepsy.

Authors:  Detlev Boison
Journal:  Glia       Date:  2011-12-22       Impact factor: 7.452

Review 7.  Epilepsy and astrocyte energy metabolism.

Authors:  Detlev Boison; Christian Steinhäuser
Journal:  Glia       Date:  2017-10-17       Impact factor: 7.452

Review 8.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

Review 9.  Adenosine and Ketogenic Treatments.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  J Caffeine Adenosine Res       Date:  2020-09-16

Review 10.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.